Segments (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table contains additional information on our consolidated revenue and net loss, including significant segment expenses (in thousands):


			Three Months Ended March 31,
			2026									2025
Collaboration and other research and development revenues			$	2,831								$	4,658
Operating expenses:
Research and development1
Employee related expenses			5,419									14,167
External research and development expenses			3,504									35,355
Facility expenses			3,224									9,393
Stock-based compensation expenses			544									907
Sublicense and license fees			2,411									17
Other expenses3			2,498									5,997
General and administrative2
Employee related expenses			2,109									5,105
Professional service expenses			1,588									2,439
Intellectual property and patent related fees			3,405									2,546
Stock-based compensation expenses			1,558									2,072
Facility and other expenses4			1,574									2,823



Interest expense related to sale of future revenues			(1,072)									(2,216)
Interest income, net			1,206									2,716
Other expense, net			(113)									(425)

Net loss			$	(24,982)								$	(76,088)

1 For the three months ended March 31, 2026, research and development includes no restructuring and impairment charges. For the three months ended March 31, 2025, research and development includes $39,243 of restructuring and impairment charges.
2 For the three months ended March 31, 2026, general and administrative includes no restructuring and impairment charges. For the three months ended March 31, 2025, general and administrative includes $1,610 of restructuring and impairment charges.
3 Other expenses primarily consists of impairment charges, consultant fees, and office expenses.
4 Facility and other expenses primarily consists of rent expense, insurance premiums, depreciation expense, software licenses, and office expenses.